The court released document about appeal decision.
https://www.tas-cas.org/fileadmin/user_upload/OG_22_08-09-10_Arbitral_Award__publication_.pdf
Few interesting details there:
"The medical expert Andrey Zholinskiy, called by the Athlete’s representatives, explained that Trimetazidine requires a prescription, a therapeutic effect requires regular intake, it is forbidden for use in children, the substance produces sideeffects like dizziness and extrapyramidal disorder which are detrimental to sports like figure skating where coordination is essential. Intake through contamination is possible, and traces can be found in samples even if somebody in the Athlete’s environment uses this medication and this could happen through contaminated objects."
"In the DADC’s opinion, in fact, the Athlete could have consumed a product which has been contaminated by the drugs used in her inner circle: “The Athlete assumes that the contamination occurred through dishes used by the Athlete and the Athlete’s grandfather (through drinking liquid from the same glass, as well). The Athlete together with her representative intend to conduct further investigation and present the results at the main hearings”.
"Considering the above, together with the Athlete’s anti-doping test history, the concentration of Trimetazidine in the Sample, the Polish study mentioned during the expert testimony, the harmful effect of the substance to children and the side effects on coordination which excludes the conscious use by the Athlete of trimetazidine to improve sports results, the opinions of the invited experts, the DADC concluded that “a low concentration of the substance of 2.1 ng / ml, in conjunction with negative doping samples taken before and after positive doping sample, indicates that that the Athlete did not take trimetazidine as a course to achieve a therapeutic effect and improve athletic performance” and that “the Athlete’s representatives were able to establish at a comfortable satisfaction of the Committee that the entry of a prohibited substance into the Athlete’s body is highly likely due to contamination”. Moreover, the DADC also took into consideration that the Athlete’s legal representative disputed the positive results of the Sample alleging that the concentration of 2.1 ng/ml, is well below the technical limit of detection of Trimetazidine, which is 10 ng/ml, and may be a technical mistake of the sample analysis in the laboratory and she confirmed at the hearing the intention to request the analysis of the “B” sample."
https://www.tas-cas.org/fileadmin/user_upload/OG_22_08-09-10_Arbitral_Award__publication_.pdf
Few interesting details there:
"The medical expert Andrey Zholinskiy, called by the Athlete’s representatives, explained that Trimetazidine requires a prescription, a therapeutic effect requires regular intake, it is forbidden for use in children, the substance produces sideeffects like dizziness and extrapyramidal disorder which are detrimental to sports like figure skating where coordination is essential. Intake through contamination is possible, and traces can be found in samples even if somebody in the Athlete’s environment uses this medication and this could happen through contaminated objects."
"In the DADC’s opinion, in fact, the Athlete could have consumed a product which has been contaminated by the drugs used in her inner circle: “The Athlete assumes that the contamination occurred through dishes used by the Athlete and the Athlete’s grandfather (through drinking liquid from the same glass, as well). The Athlete together with her representative intend to conduct further investigation and present the results at the main hearings”.
"Considering the above, together with the Athlete’s anti-doping test history, the concentration of Trimetazidine in the Sample, the Polish study mentioned during the expert testimony, the harmful effect of the substance to children and the side effects on coordination which excludes the conscious use by the Athlete of trimetazidine to improve sports results, the opinions of the invited experts, the DADC concluded that “a low concentration of the substance of 2.1 ng / ml, in conjunction with negative doping samples taken before and after positive doping sample, indicates that that the Athlete did not take trimetazidine as a course to achieve a therapeutic effect and improve athletic performance” and that “the Athlete’s representatives were able to establish at a comfortable satisfaction of the Committee that the entry of a prohibited substance into the Athlete’s body is highly likely due to contamination”. Moreover, the DADC also took into consideration that the Athlete’s legal representative disputed the positive results of the Sample alleging that the concentration of 2.1 ng/ml, is well below the technical limit of detection of Trimetazidine, which is 10 ng/ml, and may be a technical mistake of the sample analysis in the laboratory and she confirmed at the hearing the intention to request the analysis of the “B” sample."